The long-term trend of the EPS is a vital number as it helps understand the future potential of RTI Surgical. The EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been -6.70 % over the last twelve months. EPS growth is a vital measure of execution of the strategy for RTI Surgical since it indicates how well the business is allocating resources to benefit shareholders.

RTI Surgical is in the healthcare sector and trades as part of the medical devices industry. The company CEO is Camille Farhat. RTI Surgical Inc is a surgical implant company. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera, dermal tissue and bovine and porcine animal tissue.

Previous Intraday Performance:

The RTIX shares had a previous change of 3.52% which opened at 4.57 and closed at 4.70. It moved to an intraday high of 4.72 and a low of 4.49.

SeekingAlpha:  RTI Surgical, Inc. (RTIX) CEO Camille Farhat on Q3 2018 Results – Earnings Call Transcript

Historical Performance:

Over the last five trading days, RTIX shares returned 2.84% and in the past 30 trading days it returned 1.08%. Over three months, it changed 0.00%. In one year it has changed 3.30% and within that year its 52-week high was 5.10 and its 52-week low was 3.90. RTIX stock is 20.51% above its 52 Week Low.

Our calculations result in a 200 day moving average of 4.59 and a 50 day moving average of 4.54. Right now, RTIX stock is trading 2.45% above its 200 day moving average and may be a good opportunity to buy.

Business Wire:  RTI Surgical® to Acquire Paradigm Spine


The company has a market cap of $298.3m with 63.5m shares outstanding and a float of 59.7m shares. Trading volume was 386,476 shares and has experienced an average volume of 131,261 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for RTI Surgical was -0.01 which ended on 31st of December 2017. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.02. The trailing twelve month EPS is 0.10, which comes to a trailing twelve month PE of 47.00.

Below was the last reported quarterly earnings per share:
09-30-2018:  0.03
06-30-2018:  0.03
03-31-2018:  0.01
12-31-2017:  0.03

Base on our calculations, the intrinsic value per share is 6.84, which means it might be undervalued and has a margin of safety of 31.32%

Indicators Also to Watch:

Based on the latest filings, there is 24.90% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.

I calculated the beta to be 1.39

SeekingAlpha:  RTI Surgical beats by $0.02, beats on revenue

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -7.75%, return on assets is -4.01%, profit margin is -4.00%, price-to-sales is 1.03 and price-to-book is 1.59.

Company Score Card:

Results are out of six:
 3  : Growth Expectations Result
 6  : Financial Safety Result
 0  : Past Performance Result
 2  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here